Selective vasodilator and chronotropic actions of 3′,4′- dihydroxyflavonol in conscious sheep

European Journal of Pharmacology

Volumn 491, Issue 1, 2004, Pages 43-51

  Wang, Sheng ^a   Dusting, Gregory J ^a   Woodman, Owen L ^a   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiac output; Chronotropic; Flavonoid; Haemodynamics; N nitro L arginine; Nitric oxide; Regional blood flow

Indexed keywords

3',4' DIHYDROXYFLAVONOL; FLAVONOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR EFFECT; CHRONOTROPISM; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; ILIAC ARTERY; IN VIVO STUDY; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; SHEEP; VASODILATATION;

ACETAMINOPHEN; ANIMALS; CARDIAC OUTPUT; CARDIOVASCULAR AGENTS; CONSCIOUSNESS; CORONARY VESSELS; ENZYME INHIBITORS; FEMALE; HEART RATE; NITRIC OXIDE SYNTHASE; NITROARGININE; RENAL ARTERY; SHEEP; VASODILATOR AGENTS;

EID: 16544382658     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.012     Document Type: Article

References (32)

1. Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br. J. Pharmacol. 120:1997;1053-1058.
2. Bednarik J.A., May C.N. Differential regional hemodynamic effects of corticotropin in conscious sheep. Hypertension. 24:1994;49-55.
3. Bednarik J.A., May C.N. Evaluation of a transit-time system for the chronic measurement of blood flow in conscious sheep. J. Appl. Physiol. 78:1995;524-530.
4. Chan E.C., Pannangpetch P., Woodman O.L. Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J. Cardiovasc. Pharmacol. 35:2000;326-333.
5. Chan E.C., Drummond G.R., Woodman O.L. 3′,4′- Dihydroxyflavonol enhances nitric oxide bioavailability and improves vascular function after ischemia and reperfusion injury in the rat. J. Cardiovasc. Pharmacol. 42:2003;727-735.
6. Chin-Dusting J.P., Fisher L.J., Lewis T.V., Piekarska A., Nestel P.J., Husband A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br. J. Pharmacol. 133:2001;595-605.
7. Chowdhary S., Townend J.N. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin. Sci. (Lond.). 97:1999;5-17.
8. Chowdhary S., Harrington D., Bonser R.S., Coote J.H., Townend J.N. Chronotropic effects of nitric oxide in the denervated human heart. J. Physiol. 541:2002;645-651.
9. Cortes S.F., Rezende B.A., Corriu C., Medeiros I.A., Teixeira M.M., Lopes M.J., Lemos V.S. Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteries. Br. J. Pharmacol. 133:2001;849-858.
10. de Wildt D.J., Sangster B. An evaluation of derived aortic flow parameters as indices of myocardial contractility in rats. J. Pharmacol. Methods. 10:1983;55-64.
11. Diebolt M., Bucher B., Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension. 38:2001;159-165.
12. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vizcaino F., Zarzuelo A., Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 133:2001;117-124.
13. Dusting G.J. Nitric oxide in cardiovascular disorders. J. Vasc. Res. 32:1995;143-161.
14. Fitzpatrick D.F., Hirschfield S.L., Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 265:1993;H774-H778.
15. Flesch M., Schwarz A., Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am. J. Physiol. 275:1998;H1183-H1190.
16. Geleijnse J.M., Launer L.J., Van der Kuip D.A., Hofman A., Witteman J.C. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am. J. Clin. Nutr. 75:2002;880-886.
17. Herrera M.D., Zarzuelo A., Jimenez J., Marhuenda E., Duarte J. Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen. Pharmacol. 27:1996;273-277.
18. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011.
19. Hollman P.C., van Trijp J.M., Buysman M.N., van der Gaag M.S., Mengelers M.J., de Vries J.H., Katan M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418:1997;152-156.
20. Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 312:1996;478-481.
21. Lampe J.W. Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J. Nutr. 133(Suppl. 3):2003;956S-964S.
22. Leikert J.F., Rathel T.R., Wohlfart P., Cheynier V., Vollmar A.M., Dirsch V.M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 106:2002;1614-1617.
23. Liew R., Williams J.K., Collins P., MacLeod K.T. Soy-derived isoflavones exert opposing actions on guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 304:2003;985-993.
24. Middleton E. Jr., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52:2000;673-751.
25. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., van Leeuwen P.A. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:2001;418-425.
26. Perez-Vizcaino F., Ibarra M., Cogolludo A.L., Duarte J., Zaragoza-Arnaez F., Moreno L., Lopez-Lopez G., Tamargo J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J. Pharmacol. Exp. Ther. 302:2002;66-72.
27. Rendig S.V., Symons J.D., Longhurst J.C., Amsterdam E.A. Effects of red wine, alcohol, and quercetin on coronary resistance and conductance arteries. J. Cardiovasc. Pharmacol. 38:2001;219-227.
28. Taubert D., Berkels R., Klaus W., Roesen R. Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: essential structural features. J. Cardiovasc. Pharmacol. 40:2002;701-713.
29. G-nitro-L-arginine in conscious sheep. J. Cardiovasc. Pharmacol. 24:1994;144-150.
30. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur. Heart J. 18(Suppl. E):1997;E19-E29.
31. Wang S., May C.N., Dusting G.J., Woodman O.L. 3′,4′- Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischemia and reperfusion in sheep. J. Am. Coll. Cardiol. 39(Suppl. B):2002;11B-12B.
32. Yochum L., Kushi L.H., Meyer K., Folsom A.R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol. 149:1999;943-949.